Proteins and protein pattern differences between glioma cell lines and glioblastoma multiforme.
about
The epidermal growth factor receptor variant III (EGFRvIII): where wild things are alteredDMA, a bisbenzimidazole, offers radioprotection by promoting NFκB transactivation through NIK/IKK in human glioma cellsBiomarker discovery: a proteomic approach for brain cancer profiling.Application and implementation of selective tissue microdissection and proteomic profiling in neurological disease.Proteomic analysis of gliomas.Proteomic data in meningiomas: post-proteomic analysis can reveal novel pathophysiological pathways.Biochemical signatures of doppel protein in human astrocytomas to support prediction in tumor malignancy.Proteomic changes in the rat brain induced by homogenous irradiation and by the bystander effect resulting from high energy synchrotron X-ray microbeams.A Cell-Surface Membrane Protein Signature for Glioblastoma.Establishment and characterization of primary glioblastoma cell lines from fresh and frozen material: a detailed comparison.Pathway-specific differences between tumor cell lines and normal and tumor tissue cells.Proteomics of gliomas: initial biomarker discovery and evolution of technology.3D culture broadly regulates tumor cell hypoxia response and angiogenesis via pro-inflammatory pathways.A Potential Role for the Inhibition of PI3K Signaling in Glioblastoma Therapy.Proteomic analysis of glioma chemoresistance.Uniformity under in vitro conditions: Changes in the phenotype of cancer cell lines derived from different medulloblastoma subgroups.Comparison of multidimensional shotgun technologies targeting tissue proteomics.Proteomic identification of glutamine synthetase as a differential marker for oligodendrogliomas and astrocytomas.Cell line with endogenous EGFRvIII expression is a suitable model for research and drug development purposes.Protein profiling of formalin fixed paraffin embedded tissue: Identification of potential biomarkers for pediatric brainstem glioma.Prognostic markers of astrocytoma: how to predict the unpredictable?E2F transcription factors associated with up-regulated genes in glioblastoma.Insights into molecular therapy of glioma: current challenges and next generation blueprintProteomics-based analysis of invasion-related proteins in malignant gliomas.Biomarkers and therapeutic advances in glioblastoma multiforme.Cluster and Principal Component Analysis of Human Glioblastoma Multiforme (GBM) Tumor Proteome.Proteomic responses in the gills of fathead minnows (Pimephales promelas, Rafinesque, 1820) after 6 months and 2 years of continuous exposure to environmentally relevant dietary 226Ra.Identification of Plasma Membrane Glycoproteins Specific to Human Glioblastoma Multiforme Cells Using Lectin Arrays and LC-MS/MS.The effects of PI3K-mediated signalling on glioblastoma cell behaviour.Immunohistochemical expression of stem cell, endothelial cell, and chemosensitivity markers in primary glioma spheroids cultured in serum-containing and serum-free medium.The role of DNA methylation in ST6Gal1 expression in gliomas.Enhanced proteasomal activity is essential for long term survival and recurrence of innately radiation resistant residual glioblastoma cells.
P2860
Q27015045-0FE7BE78-50EF-439F-912F-F885DB211173Q28480602-497CC872-F738-442D-8615-30830B28855BQ30159478-CDF7E27B-66FE-4D4A-93C6-0041054C1AABQ30360876-88219102-CBF1-4438-92AD-323806018D6DQ33309684-692AD6A8-600D-4FDA-870B-BAD74C671A34Q33790175-80035CD1-6F3E-4626-BDF9-48E487E1F05FQ34210883-7CD92817-95B1-49C1-869F-93FA9A1A237FQ34419688-0E3ADDB8-79D9-4370-B486-9C1AABC7E2F3Q34554512-14735CF4-1D88-4EAF-AD1C-3074DBA1B43AQ34948627-82921F89-97E4-4695-9DF4-C63559B2E5C3Q35129156-5D31785A-8213-4581-97CC-73CFE3FB1CEBQ35170365-17695E17-418F-4397-83B1-5D364E26248BQ35563684-56F7ED25-2D82-4525-A027-ACE8B2C57AE7Q35677134-A22509A7-2FB2-4F1F-AA34-3CE2DD4C8177Q35778723-AEA80BAE-FAE6-4301-9946-13B3E576F9CFQ36288376-8FF22D47-8FDC-4CBE-AB3B-BB9BD0DE163CQ36302640-8468CB70-7F02-4EDF-B924-DCF44FEE0D74Q36602694-A63B7429-8A80-4A9C-ABA2-6CD4C241FAADQ37362563-C5638E3F-8D17-4A0D-98EF-9A08684A269AQ37533281-98D299C6-8529-4233-9441-2EDCBA8F75AAQ38089921-F82E5E52-1798-44D8-85FA-ECFA71031931Q38725917-DD6ED9F4-E056-4D2E-A111-5083152A5CBAQ39187306-ABE2744B-A455-4DD1-83A8-412C2786B72CQ39250856-EF61EC78-06EB-4056-800E-D650E25EB55BQ40070524-9A800B06-CC13-46AC-8654-C14ACF9407B7Q42196276-A7D3175E-513E-404B-BC0E-91D9F9384B24Q46810148-ECD77E4B-8530-4A47-9FC3-60834F53836BQ47349973-DB74B2AF-F3FF-4F29-BB85-9267121460D7Q47945880-B47FBFBB-C71C-49C1-9212-B87B8D872B5CQ48230920-75342BB9-8130-4538-8241-8D8FB7F02AEDQ51205890-32B94081-1DB3-42FF-9F2A-63CE8FA59775Q55379488-B021D08C-D7B7-4039-9CC3-297623143D2E
P2860
Proteins and protein pattern differences between glioma cell lines and glioblastoma multiforme.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Proteins and protein pattern d ...... s and glioblastoma multiforme.
@en
Proteins and protein pattern d ...... s and glioblastoma multiforme.
@nl
type
label
Proteins and protein pattern d ...... s and glioblastoma multiforme.
@en
Proteins and protein pattern d ...... s and glioblastoma multiforme.
@nl
prefLabel
Proteins and protein pattern d ...... s and glioblastoma multiforme.
@en
Proteins and protein pattern d ...... s and glioblastoma multiforme.
@nl
P2093
P1476
Proteins and protein pattern d ...... s and glioblastoma multiforme.
@en
P2093
Alexander O Vortmeyer
Edward H Oldfield
Hiroaki Okamoto
Makoto Furuta
Robert J Weil
Timothy W Vogel
Weifen Zeng
Youn-Soo Lee
Zhengping Zhuang
P304
P356
10.1158/1078-0432.CCR-04-2115
P407
P577
2005-05-01T00:00:00Z